©2024 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors